Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Northwest Bioth Cmn (NWBO)

Northwest Bioth Cmn (NWBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Northwest Bioth Cmn 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 USA

www.nwbio.com P: 240-497-9024

Description:

Northwest Biotherapeutics, Inc. is a biotechnology company focused on discovering, developing, and commercializing immunotherapy products that safely generate and enhance immune system responses to treat cancer.

Key Statistics

Overview:

Market Capitalization, $K 578,027
Enterprise Value, $K 594,617
Shares Outstanding, K 1,203,973
Annual Sales, $ 1,930 K
Annual Net Income, $ -62,600 K
Last Quarter Sales, $ 450 K
Last Quarter Net Income, $ -18,920 K
EBIT, $ -55,510 K
EBITDA, $ -51,610 K
60-Month Beta -0.68
% of Insider Shareholders 13.90%
% of Institutional Shareholders 0.04%
Float, K 1,036,621
% Float 86.10%
Short Volume Ratio 0.55

Growth:

1-Year Return -3.98%
3-Year Return -66.43%
5-Year Return 54.57%
5-Year Revenue Growth 370.73%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.02 on 03/05/24
Latest Earnings Date 05/08/24
Earnings Per Share ttm -0.06
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year 33.33%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-16 on 09/26/12

NWBO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -207.51%
Profit Margin % -3,243.52%
Debt/Equity 0.00
Price/Sales 299.12
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.04
Interest Coverage -10.95
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar